Get the Stockscreener App
53.72
0.96%
0.51
After Hours:
52.75
-0.97
-1.81%
Doximity Inc stock is traded at $53.72, with a volume of 753.97K.
It is up +0.96% in the last 24 hours and up +1.94% over the past month.
Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.
See More
Previous Close:
$53.21
Open:
$53.22
24h Volume:
753.97K
Relative Volume:
0.40
Market Cap:
$10.03B
Revenue:
$516.85M
Net Income/Loss:
$174.11M
P/E Ratio:
61.75
EPS:
0.87
Net Cash Flow:
$217.38M
1W Performance:
+3.11%
1M Performance:
+1.94%
6M Performance:
+85.31%
1Y Performance:
+82.35%
1-Day Range:
$52.95
$54.43
1-Week Range:
$49.01
$54.43
52-Week Range:
$22.96
$61.75
Doximity Inc Stock (DOCS) Company Profile
Name
Doximity Inc
Sector
Industry
Phone
(650) 549-4330
Address
500 THIRD STREET, SAN FRANCISCO
Compare DOCS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
53.72 | 10.03B | 516.85M | 174.11M | 217.38M | 0.87 |
|
VEEV
Veeva Systems Inc
|
216.59 | 35.16B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
73.51 | 12.70B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
HQY
Healthequity Inc
|
102.42 | 8.88B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.47 | 6.45B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-24 | Initiated | Stephens | Equal-Weight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Neutral |
| Nov-14-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Nov-13-24 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-08-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Nov-08-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Oct-15-24 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-09-24 | Upgrade | Needham | Hold → Buy |
| Jul-18-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Apr-25-24 | Upgrade | JP Morgan | Underweight → Neutral |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Jan-02-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Aug-09-23 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-09-23 | Downgrade | Needham | Buy → Hold |
| Aug-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-01-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-06-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-31-22 | Initiated | Wells Fargo | Overweight |
| Oct-24-22 | Initiated | Evercore ISI | In-line |
| Oct-13-22 | Initiated | BTIG Research | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-28-22 | Initiated | Berenberg | Buy |
| May-18-22 | Reiterated | BofA Securities | Neutral |
| May-18-22 | Reiterated | Goldman | Buy |
| May-18-22 | Reiterated | Guggenheim | Buy |
| May-18-22 | Reiterated | Jefferies | Buy |
| May-18-22 | Reiterated | Morgan Stanley | Equal-Weight |
| May-18-22 | Reiterated | Needham | Buy |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-04-22 | Initiated | BofA Securities | Neutral |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-14-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Nov-17-21 | Initiated | Robert W. Baird | Outperform |
| Nov-10-21 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-21 | Reiterated | Goldman | Neutral |
| Nov-10-21 | Reiterated | Morgan Stanley | Equal-Weight |
| Nov-10-21 | Reiterated | Needham | Buy |
| Nov-10-21 | Reiterated | Piper Sandler | Overweight |
| Aug-26-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-19-21 | Initiated | Canaccord Genuity | Buy |
| Jul-19-21 | Initiated | Goldman | Neutral |
| Jul-19-21 | Initiated | JP Morgan | Overweight |
| Jul-19-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-21 | Initiated | Piper Sandler | Overweight |
| Jul-19-21 | Initiated | Raymond James | Outperform |
| Jul-19-21 | Initiated | SVB Leerink | Outperform |
| Jul-19-21 | Initiated | William Blair | Outperform |
View All
Doximity Inc Stock (DOCS) Latest News
Wedmont Private Capital Acquires Shares of 5,726 Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025 - Marketscreener.com
DOCSDoximity, Inc. Latest Stock News & Market Updates - StockTitan
Doximity Sets Date for Q3 FY2025 Earnings Release and Conference Call on February 6 - StockTitan
Do Doximity's (NYSE:DOCS) Earnings Warrant Your Attention? - Yahoo Finance
26,072 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by Hamilton Lane Advisors LLC - MarketBeat
33,902 Shares in Doximity, Inc. (NASDAQ:DOCS) Purchased by Burney Co. - MarketBeat
Apella Capital LLC Boosts Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
3 Telemedicine Stocks Making Healthcare More Accessible - Inkl
DOCS: 3 Telemedicine Stocks Making Healthcare More Accessible - StockNews.com
David J Yvars Group Acquires Shares of 20,966 Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
FNY Investment Advisers LLC Makes New Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Spotting Winners: Doximity (NYSE:DOCS) And Vertical Software Stocks In Q3 - Yahoo Finance
Doximity Inc (DOCS) Trading Down 5.45% on Jan 13 - GuruFocus.com
Demystifying Doximity: Insights From 15 Analyst Reviews - Benzinga
Doximity (NASDAQ:DOCS) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - MarketBeat
Doximity: Upgraded To Buy Amid Promising Growth And Strong Execution - Seeking Alpha
JPMorgan Chase & Co. Increases Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (NASDAQ:DOCS) Price Target Lowered to $65.00 at KeyCorp - MarketBeat
Looking Into Doximity's Recent Short InterestDoximity (NYSE:DOCS) - Benzinga
Doximity (DOCS) Stock Moves -0.16%: What You Should Know - MSN
Doximity (NASDAQ:DOCS) Price Target Raised to $57.00 at Bank of America - MarketBeat
Here's Why We Think Doximity (NYSE:DOCS) Is Well Worth Watching - Simply Wall St
The Zacks Analyst Blog Highlights Doximity, BrightSpring Health Services and Embecta - Yahoo Finance
Doximity (DOCS) Stock Moves -0.13%: What You Should Know - MSN
Doximity (NASDAQ:DOCS) Shares Down 5%Time to Sell? - MarketBeat
Principal Financial Group Inc. Reduces Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Given Average Rating of "Hold" by Brokerages - MarketBeat
Barclays PLC Has $2.33 Million Stock Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Franklin Resources Inc. Raises Stock Position in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity (DOCS) Ascends But Remains Behind Market: Some Facts to Note - MSN
Why Doximity Inc. (DOCS) Skyrocketed? - Insider Monkey
Why Did Doximity Inc. (DOCS) Jump Yesterday? - MSN
Forecasting The Future: 15 Analyst Projections For Doximity - Benzinga
Doximity (NASDAQ:DOCS) Coverage Initiated at Stephens - MarketBeat
Doximity's SWOT analysis: digital health leader faces growth challenges By Investing.com - Investing.com Canada
DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
Doximity (NASDAQ:DOCS) Stock Price Up 4.9%Time to Buy? - MarketBeat
Doximity's SWOT analysis: digital health leader faces growth challenges - Investing.com
Doximity, Inc.'s (NYSE:DOCS) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Simply Wall St
Is biote Corp. (BTMD) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Geode Capital Management LLC Has $124.50 Million Holdings in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity, Inc. (NASDAQ:DOCS) Stake Cut by HighTower Advisors LLC - MarketBeat
Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care - Business Wire
The Zacks Analyst Blog Highlights McKesson, Doximity and Veracyte - Yahoo Finance
Lord Abbett & CO. LLC Makes New Investment in Doximity, Inc. (NASDAQ:DOCS) - MarketBeat
Doximity's SWOT analysis: stock faces growth challenges amid strong margins - Investing.com
Doximity Inc Stock (DOCS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):